Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies.

Amr MakadyArd van VeelenPáll JonssonOwen MoseleyAnne D'AndonAnthonius de BoerHans HillegeOlaf KlungelWim Goettsch

Published in: PharmacoEconomics (2019)

In general, RWD inclusion was higher in CEAs than REAs, and was mostly used to estimate melanoma prevalence in REAs or to predict long-term effectiveness in CEAs. Differences emerged between agencies' use of RWD; however, no visible trends for RWD use over time were observed.

Keyphrases

healthcare
public health
randomized controlled trial
primary care
risk factors
systematic review
electronic health record
health information
quality improvement
health promotion
risk assessment
climate change
artificial intelligence
deep learning